Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option

Author(s): María Laura Sbaraglini, María Cristina Vanrell, Carolina Leticia Bellera, Gustavo Benaim, Carolina Carrillo, Alan Talevi, Patricia Silvia Romano

Journal Name: Current Topics in Medicinal Chemistry

Volume 16 , Issue 19 , 2016

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Neglected tropical diseases represent a major sanitary problem and a huge economic burden to endemic countries, and are currently expanding to non-endemic countries owing to migration currents. Though long abandoned in the past, recent research on novel therapeutics has already started to show results. Drug repositioning is one of the prominent, more successful strategies to approach the development of new treatments for these diseases. Here we present an overview on the limitations of the current available medications to treat African trypanosomiasis, Chagas disease and Leishmaniasis, along with a review on drug candidates presently undergoing clinical trials and drug candidates identified through drug repositioning initiatives.

Keywords: African trypanosomiasis, Chagas disease, Clinical trials, Drug discovery, Drug repositioning, Drug repurposing, Leishmaniasis, Neglected tropical diseases.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 16 February, 2016
Page: [2201 - 2222]
Pages: 22
DOI: 10.2174/1568026616666160216154309
Price: $65

Article Metrics

PDF: 75
PRC: 1